We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600132:SSEChongqing Brewery Co.Ltd Class A Analysis

Data as of 2026-03-12 - not real-time

CN¥56.60

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Chongqing Brewery is trading at CNY 56.6, just above its 20‑day SMA (≈55.65) and comfortably below the 50‑day SMA, indicating a modest upside cushion. The 14‑day RSI sits near 60, suggesting the stock is not yet overbought, while the MACD histogram remains positive, giving a mild bullish bias. A dividend yield of 6.58% is attractive, but the payout ratio exceeds 100%, raising concerns about dividend sustainability. Valuation metrics are mixed: a trailing PE of ~27 and a forward PE of ~20 point to a price that is not cheap, while the PB ratio above 13 signals a premium valuation relative to book. Operating margins are thin (‑1.6%) and operating cash flow is reported as zero, highlighting earnings quality issues. Nevertheless, the company delivers a strong ROE of roughly 37% and revenue growth of about 5% YoY, underscoring solid profitability on a relative basis. Volatility over the past 30 days is elevated at ~24%, but beta is extremely low (≈0.09), indicating limited correlation with broader market moves. The consumer‑defensive brewing sector in China carries moderate regulatory exposure due to alcohol policies, yet the brand portfolio with Carlsberg and local labels provides market resilience. Liquidity appears adequate with stable volume and average daily turnover above 4 million shares. Overall, the stock presents a blend of growth potential and value concerns, with dividend appeal tempered by payout sustainability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above short‑term support
  • Bullish MACD but neutral overall trend
  • Elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Steady revenue growth and high ROE
  • Attractive dividend yield despite payout concerns
  • Low beta suggesting limited market‑wide downside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Premium valuation relative to book and earnings
  • Potential dividend cuts due to high payout ratio
  • Strong brand portfolio supporting market position

Key Metrics & Analysis

Financial Health

Revenue Growth5.20%
Profit Margin8.36%
P/E Ratio26.8
ROE36.84%
Debt/Equity3.09
P/B Ratio13.7

Technical Analysis

TrendNeutral
RSI59.6
SupportCN¥53.90
ResistanceCN¥57.59
MA 20CN¥55.65
MA 50CN¥53.92
MA 200CN¥54.73
MACDBullish
VolumeStable
Fear & Greed Index76.14

Valuation

GradeFair
TypeBlend
Dividend Yield6.58%

Risk Assessment

Beta0.09
Volatility24.54%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.